SYNJ2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.482400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.902600E-01
Normal-vs-Stage2
6.650800E-01
Normal-vs-Stage3
5.918400E-01
Normal-vs-Stage4
3.594000E-01
Stage1-vs-Stage2
8.262000E-01
Stage1-vs-Stage3
2.074200E-01
Stage1-vs-Stage4
5.678600E-01
Stage2-vs-Stage3
2.569400E-01
Stage2-vs-Stage4
4.173600E-01
Stage3-vs-Stage4
9.696500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.603000E-01
Normal-vs-AfricanAmerican
4.988400E-01
Normal-vs-Asian
9.809000E-01
Caucasian-vs-AfricanAmerican
4.543200E-01
Caucasian-vs-Asian
4.417800E-01
AfricanAmerican-vs-Asian
3.495400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.963000E-01
Normal-vs-Female
5.677800E-01
Male-vs-Female
7.591200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.388800E-01
Normal-vs-Age(41-60Yrs)
3.126000E-01
Normal-vs-Age(61-80Yrs)
8.691200E-01
Normal-vs-Age(81-100Yrs)
8.541400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.170600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.032000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.713380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.206100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.725500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.857600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.022800E-01
Normal-vs-Daily Drinker
6.516000E-01
Normal-vs-Weekly Drinker
7.840400E-01
Normal-vs-Occasional Drinker
4.013000E-01
Normal-vs-Social Drinker
5.650400E-01
Non Drinker-vs-Daily Drinker
2.799800E-01
Non Drinker-vs-Weekly Drinker
8.501000E-01
Non Drinker-vs-Occasional Drinker
1.351010E-01
Non Drinker-vs-Social Drinker
5.127400E-01
Daily Drinker-vs-Weekly Drinker
1.792640E-01
Daily Drinker-vs-Occasional Drinker
1.004270E-02
Daily Drinker-vs-Social Drinker
5.297500E-02
Weekly Drinker-vs-Occasional Drinker
2.195800E-01
Weekly Drinker-vs-Social Drinker
6.152800E-01
Occasional Drinker-vs-Social Drinker
3.926400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.842200E-01
Normal-vs-Grade 2
7.375800E-01
Normal-vs-Grade 3
3.523000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.648800E-01
Grade 1-vs-Grade 3
9.861600E-01
Grade 1-vs-Grade 4
4.842200E-01
Grade 2-vs-Grade 3
6.128000E-01
Grade 2-vs-Grade 4
7.375800E-01
Grade 3-vs-Grade 4
3.523000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.010600E-01
Normal-vs-NonDiabetic
6.850200E-01
Diabetic-vs-NonDiabetic
3.854000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.269800E-01
Normal-vs-NoPancreatitis
7.427400E-01
Pancreatitis-vs-NoPancreatitis
8.943000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.233000E-01
Normal-vs-N1
6.701600E-01
N0-vs-N1
8.462000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.599800E-01
Normal-vs-TP53-NonMutant
8.067000E-01
TP53-Mutant-vs-TP53-NonMutant
4.292000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
